ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 178 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,375,000 | +4.6% | 190,900 | +15.1% | 1.33% | -41.1% |
| Q3 2016 | $2,271,000 | +458.0% | 165,900 | +201.1% | 2.26% | +323.0% |
| Q2 2016 | $407,000 | -46.9% | 55,100 | -54.1% | 0.54% | -49.1% |
| Q1 2016 | $767,000 | -33.7% | 120,100 | -35.1% | 1.05% | +47.1% |
| Q4 2015 | $1,157,000 | -5.7% | 185,100 | -11.9% | 0.72% | -37.9% |
| Q3 2015 | $1,227,000 | -51.4% | 210,100 | -31.1% | 1.15% | -26.6% |
| Q2 2015 | $2,523,000 | -1.3% | 305,100 | -1.6% | 1.57% | -8.0% |
| Q1 2015 | $2,555,000 | +27.3% | 310,100 | +6.1% | 1.70% | +57.9% |
| Q4 2014 | $2,007,000 | +36.5% | 292,200 | +7.3% | 1.08% | +3.9% |
| Q3 2014 | $1,470,000 | -14.5% | 272,200 | +0.8% | 1.04% | -2.9% |
| Q2 2014 | $1,720,000 | -23.1% | 270,100 | -2.7% | 1.07% | -11.4% |
| Q1 2014 | $2,237,000 | -60.7% | 277,600 | -66.8% | 1.21% | -56.1% |
| Q4 2013 | $5,695,000 | – | 835,100 | – | 2.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |